DNA repair pathway genes, such as BRCA1, BRCA2 and ATM, which are potential predictive biomarkers [27,28,29], also had a high frequency of CNVs in the present study, suggesting that HR defect might serve as a therapeutic target in cervical cancer. This evidence concerns the gene BRCA1 and cervical cancer.